For the latest COVID information Click Here.
Updated June 2025
Upadacitinib (brand name: Rinvoq®) is a medicine that belongs to a group of medicines called Janus Kinase (JAK) inhibitors. JAK inhibitors work by blocking signals involved in inflammation. Blocking these signals in rheumatoid arthritis and other conditions caused by inflammation results in less joint pain, stiffness, swelling and damage.
Upadacitinib should only be used if no suitable treatment alternatives are available in patients:
If you stop your upadacitinib treatment, your condition may get worse. Keep taking upadacitinib, unless advised by your rheumatologist to stop or unless serious side effects occur (see Side effects).
If you stop upadacitinib for any reason, you must contact your rheumatologist.
You will need to have regular check-ups with your rheumatologist as well as blood tests to monitor your condition and how well your treatment is working. The blood tests will also check for any possible side (harmful) effects.
Upadacitinib is taken as a tablet. It is a modified release tablet which means it slowly is released into your body. This also means it must be swallowed whole and should not be crushed, broken or chewed.
Take upadacitinib with a full glass of water, preferably at the same time each day, but it is better to take it a bit late than not at all. It can be taken with or without food.
If you miss a dose: Take a dose as soon as you remember. If it is almost time for your next dose, wait until then and take a regular dose. Do not take extra medicine to make up for a missed dose.
The usual dose for adults with rheumatoid arthritis and other inflammatory conditions is 15mg taken once a day.
Upadacitnib may be used on its own or with other arthritis medicines including:
There may be times where these medicines may not be right for you, always check with your doctor before taking these medicines.
Upadacitinib cannot be used with other biologic DMARDs or other JAK inhibitors (such as baricitinib, tofacitinib, etanercept and adalimumab).
Tell your doctor if you notice side effects that you think are caused by this medicine. Many side effects disappear when upadacitinib treatment is stopped.
The most common side effects in people who take upadacitinib are mild upper respiratory tract infections (runny nose, sore throat, sinus infections), nausea, cough, and fever. upadacitinib may need to be stopped for a while if you have an infection, so it is important to talk to your doctor for advice.
Infections
If you have an active infection of any kind, treatment with upadacitinib will not be started until the infection is treated successfully.
Cardiovascular risk People with rheumatoid arthritis and other inflammatory conditions have an increased risk of heart attacks and strokes. Recent reports have associated some other JAK inhibitors with an increased risk of heart attacks and similar heart problems. Ensure your doctor is aware of any problems that might increase your risk of heart problems (e.g. high blood pressure, high cholesterol, smoking) so they can be treated. Use with other medications
Some medicines can affect how well upadacitinib works and upadacitinib might also affect how well other medicines work. Medicines that may change how upadacitinib works include:
This list does not include all the medicines that might interfere with upadacitinib. You should tell your doctor and pharmacist all of the medicines you are taking or plan to take. This includes over the counter or herbal/naturopathic medicines to see if these affect upadacitinib.
Use with alcohol
You may drink alcohol while taking upadacitinib. However, if you are also taking methotrexate you should be cautious about how much alcohol you drink.
Vaccines
If you are taking upadacitinib you should not have ‘live’ vaccines such as:
Talk with your rheumatologist before receiving any vaccines.
Pneumococcal and the yearly seasonal flu vaccinations are encouraged.
For more information on vaccination including the COVID-19 vaccination go to click here.
Surgery
Depending on the surgery, you will probably need to stop upadacitinib before surgery, usually one week before surgery. It will be restarted again after the operation at a time agreed by your surgeon and rheumatologist.
Use in pregnancy and when breastfeeding